Advanced Integrated Circuit Process LLC (AICP) is a privately held entity formed in Texas on June 12, 2024, identifying AMTL LLC as its sole owner and managing member. AMTL LLC itself was established in Delaware on April 1, 2024, with public records not identifying its personnel or management. AICP is headquartered in Allen, Texas, sharing an address with a related entity, Advanced Memory Technologies LLC. No information on employee count or revenue is publicly available.
AICP operates as a non-practicing entity (NPE) or patent assertion entity (PAE). It does not develop or sell products or services. Instead, its operations involve asserting a portfolio of over 50 patents acquired from Winbond Electronics (Nuvoton Technology Corporation Japan) in July 2024. These patents, originally developed by Panasonic before its semiconductor business transfer to Nuvoton in 2020, generally relate to semiconductor fabrication and integrated circuit technologies, including FinFET technology.
The company's patent-litigation posture is that of a patent assertion entity. While the provided data shows one plaintiff case and two defendant cases, the defendant cases are Inter Partes Reviews (IPRs) at the Patent Trial and Appeal Board (PTAB), a common defensive action by alleged infringers. AICP primarily initiates litigation, notably filing suits against major semiconductor manufacturers. Its plaintiff cases are concentrated in the Eastern District of Texas, a venue frequently favored by patent plaintiffs.
AICP's most prominent tracked case is Advanced Integrated Circuit Process LLC v. Taiwan Semiconductor Manufacturing Company, Ltd., filed in September 2024 in the Eastern District of Texas, where AICP asserted multiple patents covering semiconductor circuits and fabrication. AICP also filed a separate suit against United Microelectronics Corporation (UMC) in the same district, asserting the same patent portfolio. In response to AICP's assertions, Taiwan Semiconductor Manufacturing Company (TSMC) and UMC have filed multiple IPR petitions at the PTAB to challenge the validity of the asserted patents.